-transparent.png){kind=logo}
A full length cDNA for human arylsulfatase A was cloned and sequenced. The predicted amino acid sequence comprises 507 residues. A putative signal peptide of 18 residues is followed by the NH2-terminal sequence of placental arylsulfatase A. One of the arylsulfatase A peptides ends 3 residues ahead of the predicted COOH terminus. This indicates that proteolytic processing of arylsulfatase A is confined to the cleavage of the signal peptide. The predicted sequence contains three potential N-glycosylation sites, two of which are likely to be utilized. The sequence shows no homology to any of the known sequences of lysosomal enzymes but a 35% identity to human steroid sulfatase. Transfection of monkey and baby hamster kidney cells resulted in an up to 200-fold increase of the arylsulfatase A activity. The arylsulfatase A was located in lysosome-like structures and transported to dense lysosomes in a mannose 6-phosphate receptor-dependent manner. The arylsulfatase A cDNA hybridizes to 2.0- and 3.9-kilobase species in RNA from human fibroblasts and human liver. RNA species of similar size were detected in metachromatic leukodystrophy fibroblasts of two patients, in which synthesis of arylsulfatase A polypeptides was either detectable or absent.
C Stein, and
V Gieselmann, and
J Kreysing, and
B Schmidt, and
R Pohlmann, and
A Waheed, and
H E Meyer, and
J S O'Brien, and
K von Figura
February 1990,
The Journal of biological chemistry,
C Stein, and
V Gieselmann, and
J Kreysing, and
B Schmidt, and
R Pohlmann, and
A Waheed, and
H E Meyer, and
J S O'Brien, and
K von Figura
April 1996,
Gene therapy,
C Stein, and
V Gieselmann, and
J Kreysing, and
B Schmidt, and
R Pohlmann, and
A Waheed, and
H E Meyer, and
J S O'Brien, and
K von Figura
January 1978,
Cytogenetics and cell genetics,
C Stein, and
V Gieselmann, and
J Kreysing, and
B Schmidt, and
R Pohlmann, and
A Waheed, and
H E Meyer, and
J S O'Brien, and
K von Figura
February 1987,
American journal of human genetics,
C Stein, and
V Gieselmann, and
J Kreysing, and
B Schmidt, and
R Pohlmann, and
A Waheed, and
H E Meyer, and
J S O'Brien, and
K von Figura
December 1994,
The International journal of biochemistry,
C Stein, and
V Gieselmann, and
J Kreysing, and
B Schmidt, and
R Pohlmann, and
A Waheed, and
H E Meyer, and
J S O'Brien, and
K von Figura
May 2005,
Journal of biotechnology,
C Stein, and
V Gieselmann, and
J Kreysing, and
B Schmidt, and
R Pohlmann, and
A Waheed, and
H E Meyer, and
J S O'Brien, and
K von Figura
May 1992,
Journal of vascular surgery,
C Stein, and
V Gieselmann, and
J Kreysing, and
B Schmidt, and
R Pohlmann, and
A Waheed, and
H E Meyer, and
J S O'Brien, and
K von Figura
January 1994,
Biochemical and biophysical research communications,
C Stein, and
V Gieselmann, and
J Kreysing, and
B Schmidt, and
R Pohlmann, and
A Waheed, and
H E Meyer, and
J S O'Brien, and
K von Figura
February 1994,
Biochemical and biophysical research communications,
C Stein, and
V Gieselmann, and
J Kreysing, and
B Schmidt, and
R Pohlmann, and
A Waheed, and
H E Meyer, and
J S O'Brien, and
K von Figura
January 1991,
Autoimmunity,
